Regulatory

Editor’s Note: On December 2, the European Food Safety Authority (EFSA; Parma, Italy) held a meeting in Amsterdam with the intention of clarifying its process of reviewing Article 13 and Article 14 health claims, specifically those concerning gut and immune health. The probiotics community was well represented at the meeting, which was led by members of EFSA’s Dietetic Products, Nutrition, and Allergies (NDA) panel. Below are reflections from the meeting from representatives of probiotics specialist Danisco A/S (Denmark).

Should drug and supplement companies be required to alert investors whenever any adverse-event report (AERs) over a product arises-in case an AER is predictive of a larger problem with the product that could devalue shareholder stocks?

BioAstin, the natural astaxanthin ingredient from Cyanotech Corp. (Kailua-Kona, HI), has been self-affirmed generally recognized as safe (GRAS) for use in food, beverages, and supplements, at a dose of 1.5 mg/serving.

Could FDA make a move to ban synthetic food dyes? According to an article in the Chicago Tribune, the agency has scheduled a March hearing to discuss whether these dyes may be risky to the health of young children.

Probiotic industry specialists are hoping that the FTC’s recent dispute with Dannon (White Plains, NY) over probiotic label claims will not devalue the sound science that exists within the field of probiotic science.

After a lengthy exchange of debates and rewrites, the U.S. House today passed the Food Safety Modernization Act by a vote of 215 to 144.

The FTC announced yesterday that it has entered into a consent agreement with Dannon in which the brand will drop what the FTC says are deceptive advertising claims for its probiotic Activia yogurt and DanActive dairy drink.